title: Cytomegalovirus in hematopoietic stem cell transplant recipients.
abstract: This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.
authors.affiliation: Department of Hematology, Karolinska University Hospital, S-14186 Stockholm, Sweden. Per.Ljungman@ki.se
authors.forename: Per
authors.initials: P
authors.lastname: Ljungman
authors.forename: Morgan
authors.initials: M
authors.lastname: Hakki
authors.forename: Michael
authors.initials: M
authors.lastname: Boeckh
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000472:pathogenicity; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000635:transmission*; D018562:Disease Transmission, Infectious; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D016219:Immunotherapy, Adoptive / Q000379:methods; D017735:Virus Latency
chemical_list: D000998:Antiviral Agents